by Aaron Fernandes
Two hundred participants, including those with early signs of dementia and those diagnosed with Alzheimer’s, were assessed with neuropsychological examination, MRI, and PET scans. Credit: Penn State
Scientists from Western Australia and across the nation have shown the accumulation of a protein in the brain occurs 20 years before symptoms of Alzheimer's occur, in a groundbreaking study that could prove beneficial for early intervention.
Researchers from the Australian Imaging Biomarkers and Lifestyle (AIBL) research group describe the protein Amyloid-Beta (A?) as naturally occurring in the blood and brain. These proteins aggregate to form plaques preceding the onset of Alzheimer's disease.
AIBL's Dr Samantha Burnham says this study is the first time the time-course of A? in the onset of dementia has been quantified statistically.
"There is a general consensus that one of the first things to happen during the onset of Alzheimer's is the accumulation of this plaque in the brain. However we have never known how long before the onset of disease this happens," she says.
"Our objective with this study was to say, if we have identified someone who has reached a certain threshold of A? in the brain, how long do they have before symptoms of dementia occur?"
The study involved 200 participants, including 36 with early signs of dementia and 19 already diagnosed with Alzheimer's disease. Participants were assessed every 18 months for almost four years, with neuropsychological examination, MRI, and a PET scan.
At baseline, significantly higher levels of A? were found in patients with AD and those with mild cognitive impairment than in the healthy participants.
"I was tasked with how we could take four year follow-ups from individuals at different stages of the disease and piece them together to give an understanding of what happens throughout the course of the disease," Dr Burnham says.
"All of those individual four year trajectories had to be complied together to get an overall disease level trajectory."
During the follow-ups, 82 per cent of participants showed positive rates of A? accumulation, with deposition estimated to take 19.2 years to reach the levels observed in Alzheimer's disease.
As participants began to show symptoms of AD, the rate of A? deposition slowed towards a plateau.
"There isn't currently any clear explanation for why the accumulation of amyloid beta occurs or why it aggregates and becomes a solid plaque. We just don't know at this stage," Dr Burnham says.
Dr Burnham says the predictions of the rate of preclinical changes and the onset of the clinical phase of AD will facilitate the design and timing of therapeutic interventions aimed at modifying the course of this illness.
"What that means is that we actually have quite a large window for medical interventions to slow the disease," she says.
Explore further: Scientists much closer to developing screening test for early detection of Alzheimer's disease
Medical Xpress on facebook
Related Stories
Scientists much closer to developing screening test for early detection of Alzheimer's disease
May 01, 2013
They identified blood-based biological markers that are associated with the build up of a toxic protein in the brain which occurs years before symptoms appear and irreversible brain damage has occurred.
Pathophysiology may help ID rare, early form of Alzheimer's
Jul 12, 2012
(HealthDay) -- In dominantly inherited Alzheimer's disease, clinical and biomarker changes occur decades before the expected onset of disease symptoms, according to a study published online July 11 in the ...
Blood biomarker could mark severe cognitive decline, quicker progression among Parkinson's patients
Sep 18, 2013
A genetic mutation, known as GBA, that leads to early onset of Parkinson's disease and severe cognitive impairment (in about 4 to 7 percent of all patients with the disease) also alters how specific lipids, ceramides and ...
Alzheimer's progression tracked prior to dementia
Sep 23, 2013
For years, scientists have attempted to understand how Alzheimer's disease harms the brain before memory loss and dementia are clinically detectable. Most researchers think this preclinical stage, which can ...
Fluorescent compounds allow clinicians to visualize Alzheimer's disease as it progresses
Sep 18, 2013
What if doctors could visualize all of the processes that take place in the brain during the development and progression of Alzheimer's disease? Such a window would provide a powerful aid for diagnosing the ...
Recommended for you
A single mild blast exposure can cause brain injuries with similarities to Alzheimer's disease
Sep 24, 2013
A new study published in the September issue of the Journal of Alzheimer's Disease reports that even a single mild explosion can cause changes in the brain that have similarities to those found in diseases like Alzheimer's diseas ...
Study confirms that rare mutations increase risk of late-onset Alzheimer's disease
Sep 24, 2013
Massachusetts General Hospital (MGH) researchers have identified and validated two rare gene mutations that appear to cause the common form of Alzheimer's disease (AD) that strikes after the age of 60. The two mutations occur ...
Early imaging, diagnosis of Alzheimer's leads to changes in patient care, better outcomes
Sep 24, 2013
Patients suffering from early symptoms of Alzheimer's disease who were diagnosed sooner than usual using a brain imaging test received Alzheimer-specific medications earlier than those who did not have the brain imaging results ...
Alzheimer's progression tracked prior to dementia
Sep 23, 2013
For years, scientists have attempted to understand how Alzheimer's disease harms the brain before memory loss and dementia are clinically detectable. Most researchers think this preclinical stage, which can ...
Managed care reduces hospitalizations in nursing home residents with advanced dementia
Sep 23, 2013
Nursing home residents with advanced dementia commonly experience burdensome, costly interventions that do not improve their quality of life or extend their survival. Now a new study suggests that providing intensive primary ...
Alzheimer's 'epidemic' straining caregiver, community resources: report
Sep 19, 2013
(HealthDay)—The so-called global Alzheimer's epidemic is leading to a shortage of caregivers for seniors and a lack of support for family members who look after elderly relatives, according to a new report.
User comments
© Medical Xpress 2011-2013, Phys.org network
by Aaron Fernandes
Two hundred participants, including those with early signs of dementia and those diagnosed with Alzheimer’s, were assessed with neuropsychological examination, MRI, and PET scans. Credit: Penn State
Scientists from Western Australia and across the nation have shown the accumulation of a protein in the brain occurs 20 years before symptoms of Alzheimer's occur, in a groundbreaking study that could prove beneficial for early intervention.
Researchers from the Australian Imaging Biomarkers and Lifestyle (AIBL) research group describe the protein Amyloid-Beta (A?) as naturally occurring in the blood and brain. These proteins aggregate to form plaques preceding the onset of Alzheimer's disease.
AIBL's Dr Samantha Burnham says this study is the first time the time-course of A? in the onset of dementia has been quantified statistically.
"There is a general consensus that one of the first things to happen during the onset of Alzheimer's is the accumulation of this plaque in the brain. However we have never known how long before the onset of disease this happens," she says.
"Our objective with this study was to say, if we have identified someone who has reached a certain threshold of A? in the brain, how long do they have before symptoms of dementia occur?"
The study involved 200 participants, including 36 with early signs of dementia and 19 already diagnosed with Alzheimer's disease. Participants were assessed every 18 months for almost four years, with neuropsychological examination, MRI, and a PET scan.
At baseline, significantly higher levels of A? were found in patients with AD and those with mild cognitive impairment than in the healthy participants.
"I was tasked with how we could take four year follow-ups from individuals at different stages of the disease and piece them together to give an understanding of what happens throughout the course of the disease," Dr Burnham says.
"All of those individual four year trajectories had to be complied together to get an overall disease level trajectory."
During the follow-ups, 82 per cent of participants showed positive rates of A? accumulation, with deposition estimated to take 19.2 years to reach the levels observed in Alzheimer's disease.
As participants began to show symptoms of AD, the rate of A? deposition slowed towards a plateau.
"There isn't currently any clear explanation for why the accumulation of amyloid beta occurs or why it aggregates and becomes a solid plaque. We just don't know at this stage," Dr Burnham says.
Dr Burnham says the predictions of the rate of preclinical changes and the onset of the clinical phase of AD will facilitate the design and timing of therapeutic interventions aimed at modifying the course of this illness.
"What that means is that we actually have quite a large window for medical interventions to slow the disease," she says.
Explore further: Scientists much closer to developing screening test for early detection of Alzheimer's disease
Medical Xpress on facebook
Related Stories
Scientists much closer to developing screening test for early detection of Alzheimer's disease
May 01, 2013
They identified blood-based biological markers that are associated with the build up of a toxic protein in the brain which occurs years before symptoms appear and irreversible brain damage has occurred.
Pathophysiology may help ID rare, early form of Alzheimer's
Jul 12, 2012
(HealthDay) -- In dominantly inherited Alzheimer's disease, clinical and biomarker changes occur decades before the expected onset of disease symptoms, according to a study published online July 11 in the ...
Blood biomarker could mark severe cognitive decline, quicker progression among Parkinson's patients
Sep 18, 2013
A genetic mutation, known as GBA, that leads to early onset of Parkinson's disease and severe cognitive impairment (in about 4 to 7 percent of all patients with the disease) also alters how specific lipids, ceramides and ...
Alzheimer's progression tracked prior to dementia
Sep 23, 2013
For years, scientists have attempted to understand how Alzheimer's disease harms the brain before memory loss and dementia are clinically detectable. Most researchers think this preclinical stage, which can ...
Fluorescent compounds allow clinicians to visualize Alzheimer's disease as it progresses
Sep 18, 2013
What if doctors could visualize all of the processes that take place in the brain during the development and progression of Alzheimer's disease? Such a window would provide a powerful aid for diagnosing the ...
Recommended for you
A single mild blast exposure can cause brain injuries with similarities to Alzheimer's disease
Sep 24, 2013
A new study published in the September issue of the Journal of Alzheimer's Disease reports that even a single mild explosion can cause changes in the brain that have similarities to those found in diseases like Alzheimer's diseas ...
Study confirms that rare mutations increase risk of late-onset Alzheimer's disease
Sep 24, 2013
Massachusetts General Hospital (MGH) researchers have identified and validated two rare gene mutations that appear to cause the common form of Alzheimer's disease (AD) that strikes after the age of 60. The two mutations occur ...
Early imaging, diagnosis of Alzheimer's leads to changes in patient care, better outcomes
Sep 24, 2013
Patients suffering from early symptoms of Alzheimer's disease who were diagnosed sooner than usual using a brain imaging test received Alzheimer-specific medications earlier than those who did not have the brain imaging results ...
Alzheimer's progression tracked prior to dementia
Sep 23, 2013
For years, scientists have attempted to understand how Alzheimer's disease harms the brain before memory loss and dementia are clinically detectable. Most researchers think this preclinical stage, which can ...
Managed care reduces hospitalizations in nursing home residents with advanced dementia
Sep 23, 2013
Nursing home residents with advanced dementia commonly experience burdensome, costly interventions that do not improve their quality of life or extend their survival. Now a new study suggests that providing intensive primary ...
Alzheimer's 'epidemic' straining caregiver, community resources: report
Sep 19, 2013
(HealthDay)—The so-called global Alzheimer's epidemic is leading to a shortage of caregivers for seniors and a lack of support for family members who look after elderly relatives, according to a new report.
User comments
© Medical Xpress 2011-2013, Phys.org network
0 comments:
Post a Comment